Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study

Overview of attention for article published in Journal of Translational Medicine, February 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

reddit: 1 Redditor

Readers on

mendeley: 25 Mendeley

Summary X Reddit

So far, Altmetric has seen 1 Reddit thread.

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study | Journal of Translational Medicine

User montaukwhaler, in the non small cell lung cancer subreddit, 26 Feb 2019

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.